Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.

[1]  Nirmal Singh,et al.  Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats , 2013, Pharmacology Biochemistry and Behavior.

[2]  A. Fargašová,et al.  Arsenic and selenium interactive effect on alga Desmodesmus quadricauda. , 2012, Ecotoxicology and environmental safety.

[3]  S. Prabu,et al.  RETRACTED ARTICLE: Silibinin ameliorates arsenic induced nephrotoxicity by abrogation of oxidative stress, inflammation and apoptosis in rats , 2012, Molecular Biology Reports.

[4]  R. Marcos,et al.  Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis , 2012, Archives of Toxicology.

[5]  Nirmal Singh,et al.  Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia–hyperlipidemia induced vascular dementia , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  Nirmal Singh,et al.  Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor , 2012, Pharmacology Biochemistry and Behavior.

[7]  Nirmal Singh,et al.  Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA–salt hypertension-induced vascular dementia in rats , 2012, Psychopharmacology.

[8]  J. Satayavivad,et al.  Arsenite promotes apoptosis and dysfunction in microvascular endothelial cells via an alteration of intracellular calcium homeostasis. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  P. Toselli,et al.  Microtubules as a Critical Target for Arsenic Toxicity in Lung Cells in Vitro and in Vivo , 2012, International journal of environmental research and public health.

[10]  J. Malik,et al.  Buffalo (Bubalus bubalis) Epiphyseal Proteins Counteract Arsenic-Induced Oxidative Stress in Brain, Heart, and Liver of Female Rats , 2012, Biological Trace Element Research.

[11]  Nirmal Singh,et al.  Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats , 2011, Pharmacology Biochemistry and Behavior.

[12]  A. Pant,et al.  Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. , 2011, Neurotoxicology.

[13]  M. Spedding,et al.  The protective effect of tianeptine on Gp120‐induced apoptosis in astroglial cells: role of GS and NOS, and NF‐κB suppression , 2011, British journal of pharmacology.

[14]  C. Sartori,et al.  Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms. , 2011, American journal of physiology. Heart and circulatory physiology.

[15]  D. Bailey,et al.  Neuro-oxidative-nitrosative stress in sepsis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  Kim A Connelly,et al.  Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. , 2011, The American journal of pathology.

[17]  S. O'Bryant,et al.  Long-Term Low-Level Arsenic Exposure Is Associated with Poorer Neuropsychological Functioning: A Project FRONTIER Study , 2011, International journal of environmental research and public health.

[18]  M. Valko,et al.  Arsenic: toxicity, oxidative stress and human disease , 2011, Journal of applied toxicology : JAT.

[19]  M. Wood,et al.  HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner. , 2011, Learning & memory.

[20]  I. Fomenko,et al.  Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. , 2011, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[21]  Nirmal Singh,et al.  Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats , 2011, Psychopharmacology.

[22]  M. Wehling,et al.  Challenges of Longevity in Developed Countries: Vascular Prevention of Dementia as an Immediate Clue to Tackle an Upcoming Medical, Social and Economic Stretch , 2011, Neurodegenerative Diseases.

[23]  S. O'Bryant,et al.  The Arsenic Exposure Hypothesis for Alzheimer Disease , 2010, Alzheimer disease and associated disorders.

[24]  S. Tyagi,et al.  Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[25]  N. Ma,et al.  Protection effect of taurine on nitrosative stress in the mice brain with chronic exposure to arsenic , 2010, Journal of Biomedical Science.

[26]  J. Kaur,et al.  The Novel Role of Fenofibrate in Preventing Nicotine- and Sodium Arsenite-Induced Vascular Endothelial Dysfunction in the Rat , 2010, Cardiovascular Toxicology.

[27]  Nirmal Singh,et al.  Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. , 2010, Current neurovascular research.

[28]  P. Casaccia,et al.  HDAC inhibitors and neurodegeneration: at the edge between protection and damage. , 2010, Pharmacological Research.

[29]  S. Flora,et al.  Chelation in Metal Intoxication , 2010, International journal of environmental research and public health.

[30]  M. Čolić,et al.  Nitric oxide synthase inhibitors protect cholinergic neurons against AlCl3 excitotoxicity in the rat brain , 2010, Brain Research Bulletin.

[31]  T. Tominaga,et al.  Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats , 2010, Brain Research.

[32]  Courtney A Miller,et al.  Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.

[33]  M. Firpo,et al.  Inhibition of DNA methyltransferases and histone deacetylases induces bone marrow-derived multipotent adult progenitor cells to differentiate into endothelial cells. , 2010, Ethnicity & disease.

[34]  R. Chandra,et al.  Attenuation of arsenic neurotoxicity by curcumin in rats. , 2009, Toxicology and applied pharmacology.

[35]  Yan Leng,et al.  Multiple roles of HDAC inhibition in neurodegenerative conditions , 2009, Trends in Neurosciences.

[36]  Y. Kumagai.  [Fusion of field and laboratory studies on the investigation of arsenic]. , 2009, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[37]  J. Kaur,et al.  Arsenic Exposure and Cardiovascular Disorders: An Overview , 2009, Cardiovascular Toxicology.

[38]  M. Wood,et al.  Modulation of long-term memory for object recognition via HDAC inhibition , 2009, Proceedings of the National Academy of Sciences.

[39]  S. Haggarty,et al.  HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.

[40]  A. García-Osta,et al.  Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model , 2009, Neuropsychopharmacology.

[41]  Yong Yan,et al.  Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion , 2008, Neuroscience bulletin.

[42]  A. Katyal,et al.  Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia , 2008, Brain Research.

[43]  Nirmal Singh,et al.  Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia , 2008, Pharmacology Biochemistry and Behavior.

[44]  M. Endres,et al.  Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury , 2008, Experimental Neurology.

[45]  Nirmal Singh,et al.  Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil , 2008, Journal of psychopharmacology.

[46]  T. Ramírez,et al.  Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells , 2008, Chromosoma.

[47]  Bin Chen,et al.  Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies. , 2007, Journal of medicinal chemistry.

[48]  Li-Huei Tsai,et al.  Recovery of learning and memory is associated with chromatin remodelling , 2007, Nature.

[49]  G. M. Kannan,et al.  Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. , 2007, Journal of environmental biology.

[50]  G. Cuny,et al.  FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein , 2007, Journal of Molecular Neuroscience.

[51]  A. Chiarugi,et al.  Pharmacological Inhibition of Histone Deacetylases ( HDACs ) by Suberoylanilide Hydroxamic Acid ( SAHA ) Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain , 2006 .

[52]  P. Scheipers,et al.  The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses , 2003, BMC Cancer.

[53]  M. Wientjes,et al.  Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL). , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.